146 related articles for article (PubMed ID: 18468574)
1. Memy I: a novel murine model for uterine leiomyoma using adenovirus-enhanced human fibroid explants in severe combined immune deficiency mice.
Hassan MH; Eyzaguirre E; Arafa HM; Hamada FM; Salama SA; Al-Hendy A
Am J Obstet Gynecol; 2008 Aug; 199(2):156.e1-8. PubMed ID: 18468574
[TBL] [Abstract][Full Text] [Related]
2. Establishment of a novel xenograft model for human uterine leiomyoma in immunodeficient mice.
Tsuiji K; Takeda T; Li B; Kondo A; Ito M; Yaegashi N
Tohoku J Exp Med; 2010 Sep; 222(1):55-61. PubMed ID: 20814179
[TBL] [Abstract][Full Text] [Related]
3. Effects of Phthalate Esters on Human Myometrial and Fibroid Cells: Cell Culture and NOD-SCID Mouse Data.
Kim HJ; Kim SH; Oh YS; Heo SH; Kim KH; Kim DY; Lee SR; Chae HD
Reprod Sci; 2021 Feb; 28(2):479-487. PubMed ID: 33037561
[TBL] [Abstract][Full Text] [Related]
4. Nonobese diabetic/severe combined immunodeficient murine xenograft model for human uterine leiomyoma.
Wang G; Ishikawa H; Sone K; Kobayashi T; Kim JJ; Kurita T; Shozu M
Fertil Steril; 2014 May; 101(5):1485-92. PubMed ID: 24636398
[TBL] [Abstract][Full Text] [Related]
5. Targeted Adenoviral Vector Demonstrates Enhanced Efficacy for In Vivo Gene Therapy of Uterine Leiomyoma.
Abdelaziz M; Sherif L; ElKhiary M; Nair S; Shalaby S; Mohamed S; Eziba N; El-Lakany M; Curiel D; Ismail N; Diamond MP; Al-Hendy A
Reprod Sci; 2016 Apr; 23(4):464-74. PubMed ID: 26884457
[TBL] [Abstract][Full Text] [Related]
6. Gene therapy targeting leiomyoma: adenovirus-mediated delivery of dominant-negative estrogen receptor gene shrinks uterine tumors in Eker rat model.
Hassan MH; Salama SA; Zhang D; Arafa HM; Hamada FM; Fouad H; Walker CC; Al-Hendy A
Fertil Steril; 2010 Jan; 93(1):239-50. PubMed ID: 19144333
[TBL] [Abstract][Full Text] [Related]
7. Pigment epithelium derived factor as a novel multi-target treatment for uterine fibroids.
Bar-Joseph H; Hikri E; Chuderland D; Ben-Ami I; Shalgi R
Reprod Biomed Online; 2020 Aug; 41(2):335-342. PubMed ID: 32532667
[TBL] [Abstract][Full Text] [Related]
8. Liposomal 2-Methoxyestradiol Nanoparticles for Treatment of Uterine Leiomyoma in a Patient-Derived Xenograft Mouse Model.
Borahay MA; Vincent KL; Motamedi M; Tekedereli I; Salama SA; Ozpolat B; Kilic GS
Reprod Sci; 2021 Jan; 28(1):271-277. PubMed ID: 32632769
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus-mediated delivery of a dominant-negative estrogen receptor gene in uterine leiomyoma cells abrogates estrogen- and progesterone-regulated gene expression.
Hassan MH; Salama SA; Arafa HM; Hamada FM; Al-Hendy A
J Clin Endocrinol Metab; 2007 Oct; 92(10):3949-57. PubMed ID: 17635941
[TBL] [Abstract][Full Text] [Related]
10. Novel effects of simvastatin on uterine fibroid tumors: in vitro and patient-derived xenograft mouse model study.
Borahay MA; Vincent K; Motamedi M; Sbrana E; Kilic GS; Al-Hendy A; Boehning D
Am J Obstet Gynecol; 2015 Aug; 213(2):196.e1-8. PubMed ID: 25840272
[TBL] [Abstract][Full Text] [Related]
11. Halofuginone suppresses growth of human uterine leiomyoma cells in a mouse xenograft model.
Koohestani F; Qiang W; MacNeill AL; Druschitz SA; Serna VA; Adur M; Kurita T; Nowak RA
Hum Reprod; 2016 Jul; 31(7):1540-51. PubMed ID: 27130615
[TBL] [Abstract][Full Text] [Related]
12. Targeting the long non-coding RNA MIAT for the treatment of fibroids in an animal model.
Chuang TD; Ton N; Manrique N; Rysling S; Khorram O
Clin Sci (Lond); 2024 Jun; 138(12):699-709. PubMed ID: 38817011
[TBL] [Abstract][Full Text] [Related]
13. Effects of liver depression and psychological stress on human uterine leiomyoma cells by an AR-cAMP-PKA signal transduction pathway.
Xia T; Li S; Ma R; Guan S; Li J; Li H; Zhang H; Lin Q; Zhao Z; Wang B
Taiwan J Obstet Gynecol; 2017 Jun; 56(3):291-301. PubMed ID: 28600036
[TBL] [Abstract][Full Text] [Related]
14. Application of a Patient Derived Xenograft Model for Predicative Study of Uterine Fibroid Disease.
Fritsch M; Schmidt N; Gröticke I; Frisk AL; Keator CS; Koch M; Slayden OD
PLoS One; 2015; 10(11):e0142429. PubMed ID: 26588841
[TBL] [Abstract][Full Text] [Related]
15. Xenotransplantation of uterine leiomyoma in Wistar rats: a pilot study.
Sousa WB; Garcia JB; Nogueira Neto J; Furtado PG; Anjos JA
Eur J Obstet Gynecol Reprod Biol; 2015 Jul; 190():71-5. PubMed ID: 25996518
[TBL] [Abstract][Full Text] [Related]
16. High expression of cyclooxygenase-2 in uterine fibroids and its correlation with cell proliferation.
Ke X; Dou F; Cheng Z; Dai H; Zhang W; Qu X; Ding P; Zuo X
Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):199-203. PubMed ID: 23398724
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the antiproliferative, proapoptotic, and antiangiogenic effects of a double-stranded RNA mimic complexed with polycations in an experimental mouse model of leiomyoma.
García-Pascual CM; Ferrero H; Juarez I; Martínez J; Villanueva A; Pozuelo-Rubio M; Soengas M; Tormo D; Simón C; Gómez R; Pellicer A
Fertil Steril; 2016 Feb; 105(2):529-38. PubMed ID: 26616441
[TBL] [Abstract][Full Text] [Related]
18. Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth.
Commandeur AE; Styer AK; Teixeira JM
Hum Reprod Update; 2015; 21(5):593-615. PubMed ID: 26141720
[TBL] [Abstract][Full Text] [Related]
19. Development and assessment of a general theory of cervical carcinogenesis utilizing a severe combined immunodeficiency murine-human xenograft model.
Tewari KS; Taylor JA; Liao SY; DiSaia PJ; Burger RA; Monk BJ; Hughes CC; Villarreal LP
Gynecol Oncol; 2000 Apr; 77(1):137-48. PubMed ID: 10739703
[TBL] [Abstract][Full Text] [Related]
20. A selective cyclooxygenase-2 inhibitor suppresses the growth of endometriosis xenografts via antiangiogenic activity in severe combined immunodeficiency mice.
Ozawa Y; Murakami T; Tamura M; Terada Y; Yaegashi N; Okamura K
Fertil Steril; 2006 Oct; 86(4 Suppl):1146-51. PubMed ID: 16962108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
